1 Study Coverage
1.1 Genitourinary Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Genitourinary Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Urologicals
1.2.3 Hormonal Therapy
1.2.4 Gynecological
1.2.5 Anti-infectives
1.3 Market by Application
1.3.1 Global Genitourinary Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prostate Cancer
1.3.3 Ovarian Cancer
1.3.4 Bladder Cancer
1.3.5 Cervical Cancer
1.3.6 Renal Cancer
1.3.7 Erectile Dysfunction
1.3.8 Urinary Tract Infections
1.3.9 Urinary Incontinence & Overactive Bladder
1.3.10 Sexually Transmitted Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Genitourinary Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Genitourinary Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Genitourinary Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Genitourinary Drugs Sales by Region
2.4.1 Global Genitourinary Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Genitourinary Drugs by Region (2023-2028)
2.5 Global Genitourinary Drugs Revenue by Region
2.5.1 Global Genitourinary Drugs Revenue by Region (2017-2022)
2.5.2 Global Genitourinary Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Genitourinary Drugs Sales by Manufacturers
3.1.1 Global Top Genitourinary Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Genitourinary Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genitourinary Drugs in 2021
3.2 Global Genitourinary Drugs Revenue by Manufacturers
3.2.1 Global Genitourinary Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Genitourinary Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Genitourinary Drugs Revenue in 2021
3.3 Global Genitourinary Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Genitourinary Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Genitourinary Drugs Sales by Type
4.1.1 Global Genitourinary Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Genitourinary Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Genitourinary Drugs Sales Market Share by Type (2017-2028)
4.2 Global Genitourinary Drugs Revenue by Type
4.2.1 Global Genitourinary Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Genitourinary Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Genitourinary Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Genitourinary Drugs Price by Type
4.3.1 Global Genitourinary Drugs Price by Type (2017-2022)
4.3.2 Global Genitourinary Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Genitourinary Drugs Sales by Application
5.1.1 Global Genitourinary Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Genitourinary Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Genitourinary Drugs Sales Market Share by Application (2017-2028)
5.2 Global Genitourinary Drugs Revenue by Application
5.2.1 Global Genitourinary Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Genitourinary Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Genitourinary Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Genitourinary Drugs Price by Application
5.3.1 Global Genitourinary Drugs Price by Application (2017-2022)
5.3.2 Global Genitourinary Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Genitourinary Drugs Market Size by Type
6.1.1 North America Genitourinary Drugs Sales by Type (2017-2028)
6.1.2 North America Genitourinary Drugs Revenue by Type (2017-2028)
6.2 North America Genitourinary Drugs Market Size by Application
6.2.1 North America Genitourinary Drugs Sales by Application (2017-2028)
6.2.2 North America Genitourinary Drugs Revenue by Application (2017-2028)
6.3 North America Genitourinary Drugs Market Size by Country
6.3.1 North America Genitourinary Drugs Sales by Country (2017-2028)
6.3.2 North America Genitourinary Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Genitourinary Drugs Market Size by Type
7.1.1 Europe Genitourinary Drugs Sales by Type (2017-2028)
7.1.2 Europe Genitourinary Drugs Revenue by Type (2017-2028)
7.2 Europe Genitourinary Drugs Market Size by Application
7.2.1 Europe Genitourinary Drugs Sales by Application (2017-2028)
7.2.2 Europe Genitourinary Drugs Revenue by Application (2017-2028)
7.3 Europe Genitourinary Drugs Market Size by Country
7.3.1 Europe Genitourinary Drugs Sales by Country (2017-2028)
7.3.2 Europe Genitourinary Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Genitourinary Drugs Market Size by Type
8.1.1 Asia Pacific Genitourinary Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Genitourinary Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Genitourinary Drugs Market Size by Application
8.2.1 Asia Pacific Genitourinary Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Genitourinary Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Genitourinary Drugs Market Size by Region
8.3.1 Asia Pacific Genitourinary Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Genitourinary Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Genitourinary Drugs Market Size by Type
9.1.1 Latin America Genitourinary Drugs Sales by Type (2017-2028)
9.1.2 Latin America Genitourinary Drugs Revenue by Type (2017-2028)
9.2 Latin America Genitourinary Drugs Market Size by Application
9.2.1 Latin America Genitourinary Drugs Sales by Application (2017-2028)
9.2.2 Latin America Genitourinary Drugs Revenue by Application (2017-2028)
9.3 Latin America Genitourinary Drugs Market Size by Country
9.3.1 Latin America Genitourinary Drugs Sales by Country (2017-2028)
9.3.2 Latin America Genitourinary Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Genitourinary Drugs Market Size by Type
10.1.1 Middle East and Africa Genitourinary Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Genitourinary Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Genitourinary Drugs Market Size by Application
10.2.1 Middle East and Africa Genitourinary Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Genitourinary Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Genitourinary Drugs Market Size by Country
10.3.1 Middle East and Africa Genitourinary Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Genitourinary Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Overview
11.1.3 Novartis AG Genitourinary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis AG Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis AG Recent Developments
11.2 Genentech
11.2.1 Genentech Corporation Information
11.2.2 Genentech Overview
11.2.3 Genentech Genitourinary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Genentech Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Genentech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Genitourinary Drugs Industry Chain Analysis
12.2 Genitourinary Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genitourinary Drugs Production Mode & Process
12.4 Genitourinary Drugs Sales and Marketing
12.4.1 Genitourinary Drugs Sales Channels
12.4.2 Genitourinary Drugs Distributors
12.5 Genitourinary Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Genitourinary Drugs Industry Trends
13.2 Genitourinary Drugs Market Drivers
13.3 Genitourinary Drugs Market Challenges
13.4 Genitourinary Drugs Market Restraints
14 Key Findings in The Global Genitourinary Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
